Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Hydroxychloroquine
Market Research and
Forecast Report 2021-2026
Author: Elena Anderson,
Marketing Manager |
IMARC Group
Report Description
About
IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Report Description
Report Description and Highlights
Global Hydroxychloroquine Market Research Report:
According to the latest report by IMARC Group, titled "Hydroxychloroquine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," theglobal hydroxychloroquine market reached a strong growth in 2020.
Hydroxychloroquine (HCQ) is a derivative of chloroquine with the chemical formula C18H26ClN3O. It is a chemotherapeutic agent drug that was primarily used to suppress and treat acute attacks of malaria. It is widely known to be effective against the erythrocytic forms of malarial parasites. Apart from this, it is extensively utilized for the treatment of numerous autoimmune conditions. For instance, it is used for alleviating skin problems in lupus as well as avoiding pain or swelling caused due to arthritis.
It is also being employed as a possible treatment of the rapidly spreading coronavirus disease (COVID-19) due to the immunosuppressive, anti-autophagy and antimalarial properties offered by the drug.
Request Free Sample Report:
Report Description
Report Description and Highlights
Global Hydroxychloroquine Market Trends :
The market is primarily driven by the rapid outbreak of COVID-19 across the globe. Since HCQ is widely being used as a potential treatment of the same, numerous clinical trials and experiments are currently underway to determine the efficacy of the drug against the virus. The results of these trials are expected to ascertain the positive demand for the drug on the global level.
Apart from this, the increasing occurrence of malaria and various other chronic diseases across developing and underdeveloped countries are expected to provide an impetus to the market growth. The market is further driven by the growing incidences of autoimmune diseases, such as lupus erythematosus and rheumatoid arthritis, among individuals. This, along with the growing population and increasing health awareness amid masses, is anticipated to boost the uptake of HCQ.
Extensive research and development (R&D) activities are also being conducted by several players in the field of medical sciences. This, coupled with the rising healthcare spending by several governments and the implementation of favorable government policies to promote global health, is expected to create a positive outlook for the market.
Report Description
Report Description and Highlights
Market Summary:
Breakup by Grade:
•USP Standards Grade •EP Standards Grade
•Pharmaceutical Standards Grade •Others
Breakup by Route of Administration: •Oral •Intravenous Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia
• Indonesia • Others •Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others •Latin America • Brazil • Mexico • Argentina • Columbia • Chile • Peru • Others •Others
•Middle East and Africa Turkey •Saudi Arabia
•Iran
•United Arab Emirates
Note: We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.
Competitive Landscape with Key Players: • Amneal Pharmaceuticals Inc. • Cardinal Health Inc.
• Cipla Ltd. • Ipca Laboratories Ltd. • Laurus Labs • Lupin Limited • Mylan N.V. • Novartis AG • Prasco Laboratories • Dr. Reddy’s Laboratories Ltd. • Sanofi S.A.
• Teva Pharmaceutical Industries Ltd. • Torrent Pharma
• Zydus Cadila,
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/hydroxychloroquine-market
A partial List of our Clients
We are the trusted business partners to theworld's leading corporates, governments, and institutionsA partial List of our Clients
We are the trusted business partners to theworld's leading corporates, governments, and institutionsReport Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com
